Clicky
  • home Home
  • keyboard_arrow_right LIFESTYLE
  • keyboard_arrow_right Posts
  • keyboard_arrow_rightNew insulin therapy to help manage diabetes and aid with weight loss

New insulin therapy to help manage diabetes and aid with weight loss

By: Lifestyle Reporter

Diabetes is a growing health concern world-wide, with nearly 422 million people living with the disease. In South Africa, 12.8% of adults have diabetes according to the International Diabetes Federation. Diabetes is one of the leading causes of death in South Africa.

What is Type 2 diabetes?

Diabetes is a chronic disease that has many long term effects. It occurs when either the pancreas does not produce sufficient insulin or when the body cannot effectively use the insulin it produces. As insulin is the hormone that regulates blood glucose, or blood sugar; raised blood sugar (hyperglycaemia) is a common effect of uncontrolled diabetes. Hyperglycaemia can lead to serious damage to many of the body’s systems over time, especially the nerves and blood vessels.

READ: Diabetes in teenagers: What you must know

Treating Type 2 diabetes

The easiest ways to test for diabetes is to use the glycated haemoglobin (A1C) test. This tests the average blood sugar level of a person for the past two to three months. Anything below 5.7% is considered normal, 5.7% to 6.4% is considered prediabetic, and 6.5% or higher on two separate tests indicates diabetes. If an A1C test is not available, a random blood sugar test, fasting blood sugar test or an oral glucose tolerance test can be conducted to test for diabetes.

Once diabetes is confirmed, the focus is on managing the disease to prevent long-term complications. One of the most important ways this is done is by maintaining and improving glycaemic control over time.

The most common methods used to treat diabetes include starting a diet and increasing physical activity in an effort to lose weight and lower blood glucose levels. It is also recommended that smokers quit in order to help avoid complications. Blood sugar levels will also need to be monitored to ensure that blood sugar levels stay within the target range.

If diet, exercise, and weight loss are not enough to maintain the targeted blood sugar levels, medication is the next step. This includes oral medications and injectable medications that assist in either improving insulin production or insulin function. Some medications focus on lowering glucose production or decreasing glucose absorption.

Insulin therapy is another important form of treatment for diabetes, however it is often delayed due to concerns from patients or health care practioners. Some of the most common concerns around insulin therapy include fear of potential increased hypoglycaemia risk, weight gain, and treatment complexity. Delaying insulin treatment can lead to irreversible complications, so it is vital to escalate treatment to include insulin.

READ: 60% of calls to the South African Depression and Anxiety Group are made by women

Novo Nordisk South Africa, a leading global healthcare company, is proud to be launching its new insulin therapy product in South Africa.

The new, injectable insulin therapy is a fixed ratio combination of a basal insulin and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in a single formulation. GLP-1 agonist medicines are a type of incretin-based medicine for type 2 diabetes. This type of medicine is based on the action of hormones called incretins which help control how the pancreas works. GLP-1 is a type of incretin that causes the pancreas to produce more insulin after eating, and helps keep blood sugar levels within a normal range.

According to specialist physician Dr Adri Kok, a unique characteristic of the basal insulin and GLP-1RA combination is that fixed-ratio co-formulations are available. Dr Kok explains: “These are dosed once-daily and therefore allow treatment intensification without additional daily injections. This is important because a greater number of daily injections is associated with decreased adherence, poorer quality of life and clinical inertia”.

The new therapy offers greater convenience to patients in that it only needs to be taken once a day and can be taken independently of meals. The fixed combination offers a variety of benefits to people with type  diabetes including a reduced rate of hypoglycaemic episodes, fewer injections, a lower total daily insulin dose, and even weight loss.

Diabetes is a chronic disease that needs continuous monitoring to ensure that it does not cause any irreversible complications. The sooner treatment is started, the better. Speak to your doctor today about diabetes and the treatments available to you. For more information on diabetes visit Novo Nordisk South Africa.

READ: Women’s Health: The regular screenings every woman should go for

Image courtesy of Pexels/ @Nataliya

Article source: [email protected]

Written by: Poelano



UpComing Shows

DownLoad Our Mobile App

Privacy Policy

THIS PRIVACY STATEMENT FORMS PART OF KAYA 959’S TERMS OF USE POLICY. IF YOU DO NOT AGREE WITH ANY TERM OF THIS PRIVACY STATEMENT, YOU MUST CEASE YOUR ACCESS OF THIS WEBSITE IMMEDIATELY. 

POPIA ActTo promote the protection of personal information processed by public and private bodies; to introduce certain conditions so as to establish minimum requirements for the processing of personal information; to provide for the establishment of an Information Regulator to exercise certain powers and to perform certain duties and functions in terms of this Act and the Promotion of Access to Information Act, 2000; to provide for the issuing of codes of conduct; to provide for the rights of persons regarding unsolicited electronic communications and automated decision making; to regulate the flow of personal information across the borders of the Republic; and to provide for matters connected therewith.

RECOGNISING THAT—

  • section 14 of the Constitution of the Republic of South Africa, 1996, provides that everyone has the right to privacy;
  • the right to privacy includes a right to protection against the unlawful collection, retention, dissemination and use of personal information;
  • the State must respect, protect, promote and fulfil the rights in the Bill of Rights;

AND BEARING IN MIND THAT—

  • consonant with the constitutional values of democracy and openness, the need for economic and social progress, within the framework of the information society, requires the removal of unnecessary impediments to the free flow of information, including personal information;

AND IN ORDER TO—

  • regulate, in harmony with international standards, the processing of personal information by public and private bodies in a manner that gives effect to the right to privacy subject to justifiable limitations that are aimed at protecting other rights and important interests,
  1. Definitions and Interpretation

1.1.“Personal Information” means information relating to an identifiable, living, natural person and where it is applicable, identifiable, existing juristic person, including all information as defined in the Protection of Personal Information Act 4 of 2013. 

1.2  Parliament assented to POPIA on 19 November 2013. The commencement date of section 1Part A of Chapter 5section 112 and section 113 was 11 April 2014. The commencement date of the other sections was 1 July 2020 (with the exception of section 110 and 114(4). The President of South Africa has proclaimed the POPI commencement date to be 1 July 2020.

 
1.3. “Processing” means the creation, generation, communication, storage, destruction of personal information as more fully defined in the Protection of Personal Information Act 4 of 2013.  

1.4. “You” or the “user” means any person who accesses and browses this website for any purpose. 

1.4. “Website” means the website of the KAYA 959 at URL www.kaya959.co.za or such other URL as KAYA 959 may choose from time to time.   

  1. Status and Amendments

2.1. KAYA 959 respects your privacy. This privacy policy statement sets out KAYA 959’s information gathering and dissemination practices in respect of the Website. 

2.2. This Privacy Policy governs the processing of personal information provided to KAYA 959 through your use of the Website. 

2.3. Please note that, due to legal and other developments, KAYA 959 may amend these terms and conditions from time to time.  

  1. Processing of Personal Information

3.1. By providing your personal information to KAYA 959 you acknowledge that it has been collected directly from you and consent to its processing by KAYA 959. 

3.2. Where you submit Personal Information (such as name, address, telephone number and email address) via the website (e.g. through completing any online form) the following principles are observed in the processing of that information: 

3.2.1. KAYA 959 will only collect personal information for a purpose consistent with the purpose for which it is required. The specific purpose for which information is 
collected will be apparent from the context in which it is requested. 

3.2.2. KAYA 959 will only process personal information in a manner that is adequate, relevant and not excessive in the context of the purpose for which it is processed. 

3.2.3. Personal information will only be processed for a purpose compatible with that for which it was collected, unless you have agreed to an alternative purpose in writing or KAYA 959 is permitted in terms of national legislation of general application dealing primarily with the protection of personal information. 

3.2.4. KAYA 959 will keep records of all personal Information collected and the specific purpose for which it was collected for a period of 1 (one) year from the date on which it was last used. 

3.2.5. KAYA 959 will not disclose any personal information relating to you to any third party unless your prior written agreement is obtained or KAYA 959 is required to do so by law. 

3.2.6. If personal information is released with your consent KAYA 959 will retain a record of the information released, the third party to which it was released, the reason for the release and the date of release, for a period of 1 (one) year from the date on which it was last used. 

3.2.7. KAYA 959 will destroy or delete any personal information that is no longer needed by KAYA 959 for the purpose it was initially collected, or subsequently processed. 

3.3. Note that, as permitted by the Electronic Communications and Transactions Act 25 of 2002, KAYA 959 may use personal information collected to compile profiles for statistical purposes. No information contained in the profiles or statistics will be able to be linked to any specific user.    

  1. Collection of anonymous data

4.1. KAYA 959 may use standard technology to collect information about the use of this website. This technology is not able to identify individual users but simply allows KAYA 959 to collect statistics. 

4.2. KAYA 959 may utilise temporary or session cookies to keep track of users’ browsing habits. A cookie is a small file that is placed on your hard drive in order to keep a record of your interaction with this website and facilitate user convenience. 

4.2.1. Cookies by themselves will not be used to identify users personally but may be used to compile identified statistics relating to use of services offered or to provide KAYA 959 with feedback on the performance of this website. 

4.2.2. The following classes of information may be collected in respect of users who have enabled cookies: 

4.2.2.1. The browser software used; 

4.2.2.2. IP address; 

4.2.2.3. Date and time of activities while visiting the website; 

4.2.2.4. URLs of internal pages visited; and 

4.2.2.5. referrers. 

4.3. If you do not wish cookies to be employed to customize your interaction with this website it is possible to alter the manner in which your browser handles cookies. Please note that, if this is done, certain services on this website may not be available. 

  1. Security

5.1. KAYA 959 takes reasonable measures to ensure the security and integrity of information submitted to or collected by this website, but cannot under any circumstances be held liable for any loss or other damage sustained by you as a result of unlawful access to or dissemination of any personal information by a third party. 

  1. Links to other websites

6.1. KAYA 959 has no control over and accepts no responsibility for the privacy practices of any third party websites to which hyperlinks may have been provided and KAYA 959 strongly recommends that you review the privacy policy of any website you visit before using it further. 

  1. Queries

7.1. If you have any queries about this privacy policy please contact us by emailing [email protected]